<code id='FF65649FF2'></code><style id='FF65649FF2'></style>
    • <acronym id='FF65649FF2'></acronym>
      <center id='FF65649FF2'><center id='FF65649FF2'><tfoot id='FF65649FF2'></tfoot></center><abbr id='FF65649FF2'><dir id='FF65649FF2'><tfoot id='FF65649FF2'></tfoot><noframes id='FF65649FF2'>

    • <optgroup id='FF65649FF2'><strike id='FF65649FF2'><sup id='FF65649FF2'></sup></strike><code id='FF65649FF2'></code></optgroup>
        1. <b id='FF65649FF2'><label id='FF65649FF2'><select id='FF65649FF2'><dt id='FF65649FF2'><span id='FF65649FF2'></span></dt></select></label></b><u id='FF65649FF2'></u>
          <i id='FF65649FF2'><strike id='FF65649FF2'><tt id='FF65649FF2'><pre id='FF65649FF2'></pre></tt></strike></i>

          knowledge

          knowledge

          author:knowledge    Page View:74
          Influenza A virions
          F. A. Murphy/CDC

          Vir Biotechnology said Thursday that a long-acting antibody drug designed to protect healthy individuals from influenza A failed to do so in a nearly 3,000-person clinical trial.

          Volunteers who received the highest dose of the drug, known as VIR-2482, were only 16% less likely than the placebo group to develop symptomatic influenza A infections, as defined by trial criteria, over a seven-month period. The difference was not statistically significant.

          advertisement

          The results are a setback in broader efforts to develop better protective measures against both seasonal and potential pandemic influenza strains. In the short term, Vir and outside experts hoped VIR-2482 could provide additional annual protection for at-risk groups like older adults, as flu vaccines are often only modestly effective.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more
          How corporate America is slashing DEI workers amid backlash to diversity programs
          How corporate America is slashing DEI workers amid backlash to diversity programs

          2:36Anemptyconferenceroomisseeninthisundatedstockphoto.Pgiam/STOCKPHOTO/GettyImagesYearsafterthedeat

          read more
          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more

          CDC wastewater surveillance dashboard to track bird flu hotspots

          GodofredoA.Vásquez/APReluctanceamongdairyfarmerstoreportH5N1birdfluoutbreakswithintheirherdsorallowt